Low toxicity of high-dose CTM followed by autologous stem cell reinfusion for high-risk breast cancer

被引：0

作者：

Kruger, WH ^{[1
]}

Kroger, N ^{[1
]}

Kolbe, K ^{[1
]}

Huber, C ^{[1
]}

Gieseking, F ^{[1
]}

Janicke, F ^{[1
]}

Konigsmann, M ^{[1
]}

Berdel, WE ^{[1
]}

Kerschgens, C ^{[1
]}

Mayr, AC ^{[1
]}

Schafer-Eckert, K ^{[1
]}

Wandt, H ^{[1
]}

Schultze, W ^{[1
]}

Fuss, H ^{[1
]}

Metzner, B ^{[1
]}

Illiger, HJ ^{[1
]}

Frickhofen, N ^{[1
]}

Mobus, V ^{[1
]}

Hossfeld, DK ^{[1
]}

Jonat, W ^{[1
]}

Zander, AR ^{[1
]}

机构：

[1] Univ Hamburg, Hosp Eppendorf, Dept Oncol Haematol, BMT Unit, D-20246 Hamburg, Germany

来源：

BONE MARROW TRANSPLANTATION | 1998年 / 21卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

221

引用

页码：S62 / S62

页数：1

共 50 条

[21] High-dose chemotherapy with autologous stem cell rescue in breast cancer
Dillman, RO
Barth, NM
Nayak, SK
DeLeon, C
OConnor, A
Morrelli, L
BREAST CANCER RESEARCH AND TREATMENT, 1996, 37 (03) : 277 - 289
[22] High-dose chemotherapy and autologous stem cell transplantation for breast cancer
Baynes, RD
Dansey, RD
Klein, JL
Karanes, C
Cassells, L
Abella, E
Wei, WZ
Galy, A
Du, W
Wood, G
Peters, WP
CANCER INVESTIGATION, 2000, 18 (05) : 440 - 455
[23] Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer
Hohaus, S
Wallwiener, D
Martin, S
Voso, MT
Huober, J
Fersis, N
Bastert, G
Haas, R
SEMINARS IN ONCOLOGY, 1998, 25 (02) : 7 - 11
[24] High-dose chemotherapy in high-risk breast cancer
de Boer R.
Breast Cancer Research, 2 (1)
[25] High-dose chemotherapy in high-risk breast cancer
Price, LA
LANCET, 1998, 352 (9139): : 1551 - 1552
[26] Survival of children with high-risk neuroblastoma after conventional treatment followed by high-dose chemotherapy and autologous stem cell transplantation
Caldas, G
Lacerda, AF
Neto, A
Vieira, E
Pereira, F
Ribeiro, MJ
Chagas, M
Ambrosio, A
Miranda, N
Leal-da-Costa, F
Passos-Coelho, JL
Abecasis, M
BONE MARROW TRANSPLANTATION, 2004, 33 : S225 - S225
[27] Quality of Life after Autologous Peripheral Blood Stem Cell Transplantation and High-Dose Chemotherapy in High-Risk Breast Cancer Patients
Zhang, Li
Tong, Zhongsheng
Li, Shufen
Ren, Xiubao
Ren, Baozhu
Wang, Xu
Cao, Shui
Wang, Chen
He, Lihong
BREAST CARE, 2009, 4 (06) : 379 - 386
[28] Genomic imbalances predict outcome in patients with high-risk breast cancer treated with high-dose chemotherapy and autologous stem cell transplantation
Climent, J
Martinez-Climent, JA
Blesa, D
Marugan, I
Saez, R
Sanchez, D
Garcia, MJ
Azagra, P
Lluch, A
Garcia-Conde, J
BONE MARROW TRANSPLANTATION, 2002, 29 : S190 - S190
[29] High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer
Bearman, SI
Shpall, EJ
Jones, RB
Cagnoni, PJ
Ross, M
SEMINARS IN ONCOLOGY, 1996, 23 (01) : 60 - 67
[30] High-dose therapy with autologous stem cell rescue in patients with breast cancer at high risk relapse.
Farjami, S
Kancherla, R
Qureshi, Z
Hoang, A
Puccio, C
Mittelman, A
Seiter, K
Ahmed, T
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 83S - 83S

← 1 2 3 4 5 →